Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Improved Relapse Rate, T Cell Recovery and Engraftment in High Risk Hematological Malignancies with Enhanced Lympho-Depletion Prior to T-Cell Replete Peripheral Blood Haploidentical (HID) Hematopoietic Stem Cell Transplantation (HCT)

Yasser Khaled, MD, Joshua Boss, RN, OCN, BMTCN, Joel Gradowski, MD, Robert Bradley, MD, Jason C. Chandler, MD

Blood (2018) 132 (Supplement 1): 2117.

https://doi.org/10.1182/blood-2018-99-115290

Published: 2018

Journal Articles

T-Cell Replete Peripheral Blood Haploidentical Transplant Using Immunogenic Dose of Cyclophosphamide with Fludarabine and Melphalan Results in Enhanced Cytokine Release Syndrome (CRS) with Robust Immune Recovery and Low Relapse Rates

Yasser Khaled, MD, Jason C. Chandler, MD, Joshua Boss, RN, OCN, Arnel Pallera, MD, Michael G. Martin, MD, Robert Bradley, MD, Robert Johnson, MD

Blood (2017) 130 (Supplement 1): 1934.

https://doi.org/10.1182/blood.V130.Suppl_1.1934.1934

Published: 2017

Journal Articles

Synthetic Lethal Interactions of MDS-Associated Spliceosomal Gene Mutations Identifies the Basis for Their Mutual Exclusivity

Stanley Chun-Wei Lee, PhD, Khrystyna Dilai, Esther A. Obeng, MDPhD, Eunhee Kim, PhD, Jean-Baptiste Micol, MD PhD, Akihide Yoshimi, MD PhD, Christophe Willekens, MD, Daichi Inoue, Véronique Saada, PharmD, Hana Cho, Young Rock Chung, MS, James Palacino, PhD, Michael Seiler, PhD, Silvia Buonamici, PhD, Peter Smith, Benjamin L. Ebert, MD PhD, Robert Bradley, PhD, Omar Abdel-Wahab, MD

Blood (2016) 128 (22): 961.

https://doi.org/10.1182/blood.V128.22.961.961

Published: 2016

Journal Articles

Isogenic iPSC Models of SRSF2 -Mutant Myelodysplastic Syndrome Capture Disease Phenotypes, Splicing Defects and Drug Responses

Chan-Jung Chang, PhD, Andriana Kotini, PhD, Julie Teruya-Feldstein, MD, Omar Abdel-Wahab, MD, Robert Bradley, PhD, Eirini P. Papapetrou, MD PhD

Blood (2016) 128 (22): 962.

https://doi.org/10.1182/blood.V128.22.962.962

Published: 2016

Journal Articles

Pre-Transplant Low Dose Cyclophosphamide Enhances Engraftment and Immune Reconstitution in Haploidentical Hematopoietic Stem Cell Transplant (HCT) Recipients Receiving Total Body Radiation (TBI) Free Reduced Intensity Conditioning with Post- Transplant Cyclophosphamide (PTCY)

Yasser Khaled, MD, George Yaghmour, MD, Christy R Parks, FNP, Deborah Lamontagne, MLS(ASCP)CM, Joshua Boss, RN, Diwura Owolabi, PharmD, BCOP, Sallyanne C. Fossey, PhD, Lisa Murphy, MT(ASCP), Robert Bradley, MD

Blood (2016) 128 (22): 3431.

https://doi.org/10.1182/blood.V128.22.3431.3431

Published: 2016

Journal Articles

Impact Of Patient, Disease and Plasma Exchange Characteristics On The Outcomes Of Thrombotic Thrombocytopenic Purpura In a Retrospective Cohort Study

Amna G Khattak, Mansoor Ul Haq, MD, Fnu Kaweeta, MD, Mehmet Kocak, Ph D, Robert Bradley, Alva B. Weir, MD

Blood (2013) 122 (21): 2359.

https://doi.org/10.1182/blood.V122.21.2359.2359

Published: 2013

Journal Articles

A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies

Jeffrey E. Lancet, MD, B. Douglas Smith, MD, Robert Bradley, Rami S. Komrokji, MD, Florentina Teofilovici, MD, David A. Rizzieri, MD

Blood (2010) 116 (21): 3294.

https://doi.org/10.1182/blood.V116.21.3294.3294

Published: 2010

Journal Articles

A Phase I Study of the Potent Hsp90 Inhibitor STA-9090 Administered Twice Weekly In Subjects with Hematologic Malignancies

Swaminathan Padmanabhan, MBBS, MD, Kevin R Kelly, MD, Mark Heaney, MD, PhD, Stephanie Hodges, Suzanne Chanel, RN, Mark Frattini, MD, Ronan Swords, MD, MRCPI, FRCPath, Robert Bradley, Florentina Teofilovici, MD, MS, Daniel J DeAngelo, MD, PhD

Blood (2010) 116 (21): 2898.

https://doi.org/10.1182/blood.V116.21.2898.2898

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Improved Relapse Rate, T Cell Recovery and Engraftment in High Risk Hematological Malignancies with Enhanced Lympho-Depletion Prior to T-Cell Replete Peripheral Blood Haploidentical (HID) Hematopoietic Stem Cell Transplantation (HCT)

T-Cell Replete Peripheral Blood Haploidentical Transplant Using Immunogenic Dose of Cyclophosphamide with Fludarabine and Melphalan Results in Enhanced Cytokine Release Syndrome (CRS) with Robust Immune Recovery and Low Relapse Rates

Synthetic Lethal Interactions of MDS-Associated Spliceosomal Gene Mutations Identifies the Basis for Their Mutual Exclusivity

Isogenic iPSC Models of SRSF2 -Mutant Myelodysplastic Syndrome Capture Disease Phenotypes, Splicing Defects and Drug Responses

Pre-Transplant Low Dose Cyclophosphamide Enhances Engraftment and Immune Reconstitution in Haploidentical Hematopoietic Stem Cell Transplant (HCT) Recipients Receiving Total Body Radiation (TBI) Free Reduced Intensity Conditioning with Post- Transplant Cyclophosphamide (PTCY)

Impact Of Patient, Disease and Plasma Exchange Characteristics On The Outcomes Of Thrombotic Thrombocytopenic Purpura In a Retrospective Cohort Study

A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies

A Phase I Study of the Potent Hsp90 Inhibitor STA-9090 Administered Twice Weekly In Subjects with Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only